Clinical Trials Browser

Phase 1/2 × Terminated × Immunoglobulin Light-chain Amyloidosis × Clear all

NCT05839626 2025-06-12

A Study to Investigate Safety and Efficacy With SAR445514 in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) and Relapsed/Refractory Light-chain Amyloidosis (RRLCA)

Phase 1/2 Terminated

Immunoglobulin Light-chain Amyloidosis, Multiple Myeloma